Prognostic factors for patients with liver metastases from breast cancer

Breast Cancer Research and Treatment

Volumn 96, Issue 1, 2006, Pages 53-62

  Eichbaum, Michael H R ^a   Kaltwasser, Margarete ^a   Bruckner, Thomas ^a   De Rossi, Thomas M ^a   Schneeweiss, Andreas ^a   Sohn, Christof ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Breast cancer; Liver metastases; Prognostic factors; Regional therapy; Survival

Indexed keywords

ANTHRACYCLINE; AROMATASE INHIBITOR; FLUOROURACIL; HORMONE RECEPTOR; KI 67 ANTIGEN; MITOMYCIN; PROTEIN P53; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; AGED; ARTICLE; ASCITES; BREAST CANCER; CANCER DIAGNOSIS; CANCER SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAUNDICE; KAPLAN MEIER METHOD; LIVER DYSFUNCTION; LIVER METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33645232157     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9039-1     Document Type: Article

References (30)

1. Henderson IC: Chemotherapy for metastatic breast disease. In: Harris JR, Hellmann S, Henderson IC, et al. (eds) Breast Diseases (2 ed.). J.B. Lippincott Company, Philadelphia, PA, 1991, pp 504-665
2. Hoe AL, Royle GT, Taylor I: Breast liver metastases-incidence, diagnosis and outcome. J R Soc Med 84: 714-716, 1991
3. Kamby C, Dirksen H, Vejborg I, Daugaard S, Guldhammer B, Rossing N, Mourdisen HAT: Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer. Cancer 59: 1524-1529, 1987
4. Patanaphan V, Salazar OM, Risco R: Breast cancer: metastatic pattern and their prognosis. South Med J 81(9): 1109-1112, 1988
5. Zinser JW, Hortobagyi GN, Buzdar AU, Smith TL, Fraschini G: Clinical course of breast cancer patients with liver metastases. J Clin Oncol. 5: 773-782, 1987
6. Nemato T, Dao TL: Significance of liver metastases in women with disseminated breast cancer undergoing endocrine ablative surgery. Cancer 19: 421-427, 1966
7. Viadana E, Bross IDJ, Pickren JW: An autopsy study of some routes of dissemination of cancer of the breast. Br J Cancer 27: 336-340, 1973
8. Heidemann E, Steinke B, Hartlapp J: Prognostic subgroups: the key factor for treatment outcome in metastatic breast cancer. Onkologie 16: 344-353, 1993
9. Elias D, Lasser PH, Montrucolli D, Bonvallot S, Spielmann M: Hepatectomy for liver metastases from breast cancer. Eur J Oncol 21: 510-513, 1995
10. Wyld L, Gutteridge E, Pinder SE, James JJ, Chan SY, Cheung KL, Robertson JF, Evans AJ: Prognostic factors for patients with hepatic metastases from breast cancer. Brit J Cancer 89: 284-290, 2003
11. Pritchard KI: Liver metastases: can our understanding of their biology and prognostic value contribute to a strategy for optimum therapeutic management? Eur J Cancer 33(Suppl. 7): S11-S14, 1997
12. Campbell FC, Blamey RW, Elston CW, Nicholson RI, Griffith K, Haybittle JL: Oestrogen-receptor status and sites of metastasis in breast cancer. Br J Cancer 44: 456-459, 1981
13. Kamby C, Rasmussen BR, Kristensen B: Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence. Br J Cancer 60: 252-257, 1989
14. Buzdar A: Endocrine therapy in the treatment of metastatic breast cancer. Semin Oncol 28: 291-304, 2001
15. Piccart MJ, Bernard-Marty C, Cardoso F: Non-endocrine systemic therapies in advanced breast cancer. Eur J Cancer Suppl. Vol 1(6): 287-298, 2003
16. Chan S, Friedrich K: Noel D for the study 303 group: prospective randomised trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol 17: 2351-2354, 1999
17. Eichbaum M, Schneeweiss A, de Rossi T, Bastert G: Endoscopic stenting of the common bile duct allows successful treatment of patient with excessive liver metastases from breast cancer - a case report. Am J Clin Oncol 27(6): 642-643, 2004
18. Hortobagyi GN: Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer. Semin Oncol 28(6 Suppl. 18): 43-47, 2001
19. Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Guinebretiere JM, Spielmann M, Delaloge S: An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 185(2): 158-164, 2003
20. Herfarth KK, Debus J, Lohr F, Bahner ML, Rhein B, Fritz P, Hoss A, Schlegel W, Wannenmacher MF: Stereotactic single-dose radiation therapy of liver tumors: results of a pase I/II trial. J Clin Oncol 19(1): 164-170, 2001
21. Masuda N, Yayoi E, Nakano Y, Monden T, Okamura J: Liver metastases from breast cancer - clinical features and treatment. Gan To Kagaku Ryoho 25(9): 1406-1411, 1998
22. Schneebaum S, Walker MJ, Young D, Farrar WB, Minton JP: The regional treatment of liver metastases from breast cancer. J Surg Oncol 55(1): 26-31, 1994
23. Singletary SE, Walsh G, Vauthey J, Curley S, Sawaya R, Weber KL, Meric F, Hortobagyi GN: A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 8: 241-251, 2003
24. Hortobagyi GN: Can we cure limited metastatic breast cancer? J Clin Oncol 20(3): 620-623, 2001
25. O'Reilly SM, Richards MA, Rubens RD: Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. Eur J Cancer 26: 574-577, 1990
26. Baur M, Schlappack O, Havelec L, Wrba F, Dittrich C: Prognostic significance of liver metastases as first site of generalisation in patients with breast cancer - a retrospective analysis. Acta Med Austriaca 28: 135-140, 2001
27. Leone BA, Romero A, Rabonpvich MG, Vallejo CT, Bianco A, Perez JE, Machiavelli M, Rodriguez R, Alvarez LA: Stage IV breast cancer: clinical course and survival of patients with osseous versus extraosseous metastases at initial diagnosis - the GOCS (Grupo Oncologico Cooperative del Sur) experience. Am J Clin Oncol 11(6): 618-622, 1988
28. Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G: Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59(3): 271-278, 2000
29. Mack MG, Straub R, Eichler K, et al. Laserinduzierte interstitielle Thermotherapie (LITT)-Technik, Indikation und lokale Tumorkontrolle. In: Vogl TJ, Mack MG, Balzer JO (eds) Lebermetastasen. Diagnose - Intervention - Therapie. Springer Verlag, Berlin, Heidelberg, New York (1st ed.), 2001, pp 236-251
30. Garden OJ, Graghty JG, Nagorney DM: Liver Metastases - Biology, Diagnosis and Treatment. Springer-Verlag, London Ltd, 1998